Hepatic macrophages in liver fibrosis: pathogenesis and potential therapeutic targets.

Hepatic macrophages in liver fibrosis: pathogenesis and potential therapeutic targets.

Item
http://www.wikidata.org/entity/Q36947366
SECs (Sinusoidal Endothelial Cells), Liver Microenvironment, and Fibrosis.p16(Ink4a) and senescence-associated β-galactosidase can be induced in macrophages as part of a reversible response to physiological stimuli.Nanoparticles for the treatment of liver fibrosis.miR-185 Inhibits Fibrogenic Activation of Hepatic Stellate Cells and Prevents Liver Fibrosis.Dietary fat stimulates development of NAFLD more potently than dietary fructose in Sprague-Dawley rats.Multiple liver insults synergize to accelerate experimental hepatocellular carcinoma.Effective Amelioration of Liver Fibrosis Through Lentiviral Vector Carrying in Murine ModelGulf war illness-related chemicals increase CD11b/c monocyte infiltration into the liver and aggravate hepatic cholestasis in a rodent modelTransforming Growth Factor-β-Induced Cell Plasticity in Liver Fibrosis and Hepatocarcinogenesis
P2860

Hepatic macrophages in liver fibrosis: pathogenesis and potential therapeutic targets.

Item
http://www.wikidata.org/entity/Q36947366
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Hepatic macrophages in liver fibrosis: pathogenesis and potential therapeutic targets.
@en
type
label
Hepatic macrophages in liver fibrosis: pathogenesis and potential therapeutic targets.
@en
prefLabel
Hepatic macrophages in liver fibrosis: pathogenesis and potential therapeutic targets.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P932
P356
P1433
P1476
Hepatic macrophages in liver fibrosis: pathogenesis and potential therapeutic targets.
@en
P2093
P2860
P304
P31
P356
10.1136/BMJGAST-2016-000079
P433
P478
P577
P698
P932